Pasar al contenido principal

BASES ESTRUCTURALES DE VARIOS MECANISMOS DE REGULACION DE LA SINTESIS DE PROTEINAS

PID2020-116880GB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Synthetic heparan sulfate mimics based on chitosan derivatives show broad-spectrum antiviral activity

  • Geller, Ron
  • Revuelta, Julia
  • Rusu, Luciana
  • Francés-Gómez, Clara
  • Trapero, Elena
  • Iglesias, Susana
  • Calvo Pinilla, Eva
  • Blázquez, Ana-Belén
  • Gutiérrez-Adán, Alfonso
  • Konuparamban, Acsah
  • Moreno, Oscar
  • Gómez-Martínez, María
  • Forcada-Nadal, Alicia
  • López-Redondo, Marisa
  • Llácer, José Luis
  • Llop, Jordi
  • Martín-Acebes, M. A.
  • Fernández-Mayoralas, Alfonso
Enveloped viruses enter cells by binding to receptors present on host cell membranes, which trigger internalization and membrane fusion. For many viruses, this either directly or indirectly involves interaction with membrane-anchored carbohydrates, such as heparan sulfate, providing a potential target for a broad-spectrum antiviral approach. Based on this hypothesis, we screened a library of functionalized chitosan sulfates that mimic heparan sulfate in cellular membranes for inhibition of SARS-CoV-2 and respiratory syncytial virus (RSV) entry. An array of compounds blocking SARS-CoV-2 and RSV were identified, with the lead compound displaying broad-spectrum activity against multiple viral strains and clinical isolates. Mechanism of action studies showed the drug to block viral entry irreversibly, likely via a virucidal mechanism. Importantly, the drug was non-toxic in vivo and showed potent post-exposure therapeutic activity against both SARS-CoV-2 and RSV. Together, these results highlight the potential of functionalized carbohydrates as broad-spectrum antivirals targeting respiratory viruses., Funding for this project was provided by grants SGL2021-03-009, SGL2103053, and SGL2021-03-052 from European Union NextGenerationEU/PRTR through the CSIC Global Health Platform established by EU Council Regulation 2020/2094, to RG, to MAM-A, J. R., A. F.-M., J.L.L, and the IBV-Covid19-Pipeline acknowledge the financial support provided by CSIC (grants CSIC-COV19-013, CSIC-COV19-082) and the MICIN (grants PID2019-105337RB-C21, PID2020-120322RB-C21, PID2020-116880GB-I00). RG also acknowledges funding from the Generalitat Valenciana (GVA, GVCOVID19-2020-05). MAM-A acknowledges funding from the European Union’s Horizon Europe research and innovation programme under grant agreement number 101137506 (NAVIPP)., No
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Structures of the cyanobacterial nitrogen regulators NtcA and PipX complexed to DNA shed light on DNA binding by NtcA and implicate PipX in the recruitment of RNA polymerase

  • Forcada-Nadal, Alicia
  • Bibak, Sirine
  • Salinas, Paloma
  • Contreras, Asunción
  • Rubio, Vicente
  • Llácer, José L.
  • Contreras, Asunción|||/items/3e05e693-62f8-42c3-b3c0-9d7dcd42d2b3
  • Salinas, Paloma|||/items/c6e9c0f4-3221-4d08-805b-4cbd292b1c82
The CRP-FNR (cAMP receptor protein-fumarate/nitrate reductase regulator) superfamily of transcriptional regulators includes the cyanobacterial master regulator NtcA, which orchestrates large responses of cyanobacteria to nitrogen scarcity. NtcA uses as allosteric activator 2-oxoglutarate (2OG), a signal of nitrogen poorness and carbon richness, and binds a co-activating protein (PipX) that shuttles between the signaling protein PII and NtcA depending on nitrogen richness, thus connecting PII signaling and gene expression regulation. Here, combining structural (X-ray crystallography of six types of crystals including NtcA complexes with DNA, 2OG, and PipX), modeling, and functional [electrophoretic mobility shift assays and bacterial two-hybrid (BACTH)] studies, we clarify the reasons for the exquisite specificity for the binding of NtcA to its target DNA, its mechanisms of activation by 2OG, and its co-activation by PipX. Our crystal structures of PipX–NtcA–DNA complexes prove that PipX does not interact with DNA, although it increases NtcA–DNA contacts, and that it stabilizes the active, DNA-binding-competent conformation of NtcA. Superimposition of this complex on a very recently reported cryo-electron microscopy structure of NtcA in a transcription activity complex with RNA polymerase (RNAP), shows that PipX binding helps recruit RNAP by PipX interaction with RNAP, particularly with its gamma and sigma (region 4) subunits, a structural prediction supported here by BACTH experiments.